Want to see PARK full AI Analyst Report?
PARK Stock Chart & Stats
$17.33
--
Market closed
$17.33
--
Day’s Range― - ―
52-Week Range$9.53 - $22.68
Previous CloseN/A
VolumeN/A
Average Volume (3M)96.30K
Market Cap
$84.75M
Enterprise Value$108.92
Total Cash (Recent Filing)$24.37M
Total Debt (Recent Filing)$59.75M
Price to Earnings (P/E)605.5
Beta0.29
Next Earnings
Aug 12, 2026EPS Estimate
0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding4,515,054
10 Day Avg. Volume61,908
30 Day Avg. Volume96,297
Financial Highlights & Ratios
PEG Ratio0.70
Price to Book (P/B)1.32
Price to Sales (P/S)0.12
P/FCF Ratio2.79
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.09
Revenue Forecast (FY)$257.60M
Bulls Say, Bears Say
Bulls Say
Consistent Positive Operating & Free Cash FlowSustained positive operating and free cash flow provides durable internal funding for operations, integration of acquisitions, and working capital needs. Even with reported net losses, cash conversion cushions liquidity risk and supports strategic actions such as M&A or targeted reinvestment over the next several quarters.
High Patient Retention And Expanding Provider BaseRetention above 90% and a growing roster of 221 doctors underpin recurring revenue and greater capacity utilization. Low churn and an expanding provider footprint enable predictable same-practice growth, efficient scaling of clinic hours, and durable organic revenue contribution alongside M&A activity.
Established M&A Pipeline And Integration CapabilityM&A is management's primary growth lever and a diversified acquisition pipeline plus demonstrated integration (practice management conversion) indicate operational capability to scale. A disciplined roll-up model can drive market share, economies of scale, and margin improvement over 2–6 months as integrations complete.
Bears Say
Historical Negative Equity And Elevated LeverageNegative equity through 2023–24 signals prior balance-sheet stress and raises refinancing, covenant, and investor confidence risks. The sharp 2025 step-change to positive equity improves structure but reduces trend comparability; elevated leverage still constrains flexibility and heightens sensitivity to cash flow swings.
GAAP Profitability Pressured By Share‑based CompensationElevated, IPO‑related share‑based compensation materially increases GAAP costs and suppresses reported earnings despite positive underlying EBITDA and cash flow. This structural expense profile can persist until vesting runs off, keeping GAAP profitability weak and complicating comparability for several quarters.
M&A Timing Unpredictability And Competitive MarketHeavy reliance on acquisitions for growth creates execution risk: competitive deal markets and uneven closing timing can produce volatility in revenue and scale benefits. A selective approach preserves discipline but may slow expansion, making near‑term growth dependent on variable transaction activity and integration pacing.
Park Dental Partners, Inc. News
PARK FAQ
What was Park Dental Partners, Inc.’s price range in the past 12 months?
Park Dental Partners, Inc. lowest stock price was $9.53 and its highest was $22.68 in the past 12 months.
What is Park Dental Partners, Inc.’s market cap?
Park Dental Partners, Inc.’s market cap is $84.75M.
When is Park Dental Partners, Inc.’s upcoming earnings report date?
Park Dental Partners, Inc.’s upcoming earnings report date is Aug 12, 2026 which is in 17 days.
How were Park Dental Partners, Inc.’s earnings last quarter?
Park Dental Partners, Inc. released its earnings results on May 13, 2026. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.2 by $0.24.
Is Park Dental Partners, Inc. overvalued?
According to Wall Street analysts Park Dental Partners, Inc.’s price is currently Overvalued.
Does Park Dental Partners, Inc. pay dividends?
Park Dental Partners, Inc. does not currently pay dividends.
What is Park Dental Partners, Inc.’s EPS estimate?
Park Dental Partners, Inc.’s EPS estimate is 0.2.
How many shares outstanding does Park Dental Partners, Inc. have?
Park Dental Partners, Inc. has 4,515,054 shares outstanding.
What happened to Park Dental Partners, Inc.’s price movement after its last earnings report?
Park Dental Partners, Inc. reported an EPS of $0.44 in its last earnings report, beating expectations of $0.2. Following the earnings report the stock price went down -1.749%.
Which hedge fund is a major shareholder of Park Dental Partners, Inc.?
Currently, no hedge funds are holding shares in PARK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Park Dental Partners, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Park Dental Partners, Inc.
Park Dental Partners, Inc. operates as a dental support organization, providing a wide array of non-clinical and operational assistance to dental professionals throughout Minnesota and Wisconsin. The company furnishes its network of affiliated general and multi-specialty dental practices with vital resources, including clinical and administrative staff, physical facilities, and essential equipment. Through these partnered clinics, patients can access a full spectrum of oral healthcare services, from general dentistry to specialized procedures such as oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. Founded in 1972, Park Dental Partners, Inc. is headquartered in Roseville, Minnesota.
PARK Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid operational momentum with mid-single-digit revenue growth (6.2% YoY), healthy same-practice growth (4.1%), positive adjusted EBITDA and cash flow, a strong patient retention rate (>90%), and a robust M&A pipeline and balance sheet. Near-term GAAP profitability is pressured by elevated share-based compensation (IPO vesting acceleration), higher public company costs, and a larger share count that depresses GAAP EPS versus prior year. Management maintained full-year guidance and emphasized continued investments in capacity and disciplined M&A. Overall, positive operational and liquidity indicators outweigh the near-term GAAP expense headwinds and seasonality risks.View all PARK earnings summariesPARK Stock 12 Month Forecast
Average Price Target
―Labcorp Holdings
―
Envista Holdings
―
American Well
―
DocGo
―
Concentra Group Holdings Parent, Inc.
―
Ownership Overview
―
Insiders
6.47% Mutual Funds
1.10% Other Institutional Investors
90.85% Public Companies and
Individual Investors